Serum vitamin E as a significant prognostic factor in patients with dyslipidemia disorders
ConclusionWe found that vitamin E profile was significantly lower in the dyslipidemia subjects. It is generally suggested that vitamin E monitoring might be used as a useful prognostic and therapeutic agent in dyslipidemia disorder.
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research
More News: Antidoxidants | Cardiology | Cardiovascular | Diabetes | Endocrinology | Fatty Liver Disease (FLD) | Heart | Iran Health | Liver | Liver Disease | Metabolic Syndrome | Middle East Health | Obesity | Statistics | Stroke | Study | Urology & Nephrology | Vitamin E | Vitamins